Tg Therapeutics Inc (TGTX)

Operating Expenses

$177.47M

Quarterly · Period ending: · USD

TGTX logo

TGTX Operating Expenses

Latest reported$177.47M
TGTX Quarterly Operating Expenses ($0.00 → $177.47M)
High-resolution chart · PNG

TGTX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
177,467,000
136,613,000
103,938,000
104,189,000
87,367,000
96,693,000
62,837,000
62,104,000
56,346,000
67,221,000
48,510,000
47,522,000
58,837,000
43,938,000
52,139,000
35,055,000
39,512,000
68,651,000
95,058,000
86,866,000
78,889,000
89,856,000
86,714,000
85,760,000
50,883,000
50,283,000
37,998,000
60,899,000
35,582,000
34,727,000
54,188,000
34,366,000
44,383,000
41,615,000
31,072,826
31,623,323
28,463,466
27,704,517
24,066,153
24,963,567
16,061,538
14,030,251
17,678,096
13,863,680
17,149,675
14,640,946
18,759,219
17,477,442
11,993,592
7,643,220
5,216,261
4,685,513
6,666,860
3,752,136
2,604,937
2,714,226
3,104,930
17,385,354
-268,860
261,843
322,906
566,085
446,569
515,631
525,091
529,445
341,321
395,640
477,260
557,336
-52,253
1,383,558
1,467,266
1,614,131
1,918,756
2,707,021
4,924,008
2,594,172
3,180,197
1,965,448
2,357,294
2,914,184
14,527,699
1,861,627
1,510,395
1,457,283
1,791,905
2,241,691
986,716
1,122,511
1,520,326
2,038,780
777,020
422,227
366,406
588,240
468,673
629,596
558,193
704,519
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.